Helicobacter pylori Lipopolysaccharide Upregulates MDM2 via the TLR4/MAPK/AP-1 Pathway to Promote Gastric Cancer

Yuqin Li1, Lin Xu2, Xiaolan Lu1

  • 1Department of Gastroenterology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.

PubMed
Abstract

Insights

Helicobacter pylori (HP) lipopolysaccharide (LPS) boosts gastric cancer by increasing MDM2 expression via the TLR4/MAPK/AP-1 pathway, promoting cell growth and immune suppression. MDM2 is a potential therapeutic target for HP-associated gastric cancer.

Area of Science:

  • Oncology
  • Immunology
  • Microbiology

Background:

  • Helicobacter pylori (HP) lipopolysaccharide (LPS) is a key factor in gastric cancer development, causing chronic inflammation and promoting cell proliferation.
  • While HP LPS has lower endotoxic activity than E. coli LPS, it significantly contributes to gastric cancer progression through unknown pathways.

Purpose of the Study:

  • To elucidate the specific signaling pathways involved in HP LPS-induced gastric cancer progression.
  • To investigate the role of MDM2 in HP LPS-mediated gastric tumorigenesis and immune modulation.

Main Methods:

  • Cell lines (GES-1, HGC-27, MKN-45) were treated with HP and E. coli LPS.
  • Western blotting and luciferase assays assessed MDM2 expression and activity.
  • Cell proliferation, migration, invasion, and regulatory T cell (Treg) infiltration were evaluated.
  • In vivo gastric cancer mouse models were utilized.

Main Results:

  • HP infection and HP LPS increased MDM2 levels in gastric precancerous lesions and cancers.
  • HP LPS upregulated MDM2 expression in gastric cancer cells via the TLR4/MAPK/AP-1 pathway.
  • MDM2 promoted gastric cancer cell proliferation, invasion, and Treg-mediated immunosuppression.

Conclusions:

  • HP LPS enhances MDM2 expression through the TLR4/MAPK/AP-1 signaling cascade.
  • MDM2 plays a crucial role in mediating HP LPS's protumor effects, including proliferation and immune evasion.
  • MDM2 represents a promising therapeutic target for managing HP-associated gastric cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K